FEATURED IN CANCER
Oncology Research•Sep 16, 2026
New Research Offers Fresh Insights Into Early Cancer Detection via MicroRNA Blood Panels
A multi-centre clinical trial spanning 12,000 participants shows an 89% sensitivity rate in pinpointing stage-1 malignancies through specialized circulating microRNA signatures.
HealthGhuru BureauRead Report


